• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5137112)   Today's Articles (1469)
For: Lampertico P, Agarwal K, Berg T, Buti M, Janssen HL, Papatheodoridis G, Zoulim F, Tacke F. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67:370-398. [PMID: 28427875 DOI: 10.1016/j.jhep.2017.03.021] [Citation(s) in RCA: 3751] [Impact Index Per Article: 468.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/23/2017] [Accepted: 03/23/2017] [Indexed: 02/07/2023]
Number Cited by Other Article(s)
1
Li D, Ho V, Teng CF, Tsai HW, Liu Y, Bae S, Ajoyan H, Wettengel JM, Protzer U, Gloss BS, Rockett RJ, Al Asady R, Li J, So S, George J, Douglas MW, Tu T. Novel digital droplet inverse PCR assay shows that natural clearance of hepatitis B infection is associated with fewer viral integrations. Emerg Microbes Infect 2025;14:2450025. [PMID: 39749570 PMCID: PMC11731057 DOI: 10.1080/22221751.2025.2450025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2024] [Revised: 12/30/2024] [Accepted: 01/01/2025] [Indexed: 01/04/2025]
2
Oludoun O, Abiodun O, Gbadamosi B, Oladejo J, Akinola E, Emuoyibofarhe O, Adebimpe O. The role of spontaneous clearance on fractional analysis of HBV. Infect Dis Model 2025;10:1019-1036. [PMID: 40520250 PMCID: PMC12167083 DOI: 10.1016/j.idm.2025.05.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2025] [Revised: 05/13/2025] [Accepted: 05/23/2025] [Indexed: 06/18/2025]  Open
3
Wang X, Lai C, Li R, Lei J, Xie Y, Li Z, Tang Q, He Q, Zhang H, Zhang Z, Wang F. High HBsAg clearance rate and viral dynamics in HBeAg-positive, ALT-normal children and adolescents with chronic HBV infection: results from the prospective sprout project. Emerg Microbes Infect 2025;14:2516173. [PMID: 40469009 DOI: 10.1080/22221751.2025.2516173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2025] [Revised: 04/22/2025] [Accepted: 05/30/2025] [Indexed: 06/28/2025]
4
Ding L, Huang J, Huang S. The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus. Hum Vaccin Immunother 2025;21:2445283. [PMID: 39754388 DOI: 10.1080/21645515.2024.2445283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2024] [Revised: 11/30/2024] [Accepted: 12/17/2024] [Indexed: 01/06/2025]  Open
5
Zhang L, Zhang Q, Liu J, Wu W, Jiang Z, Yan B, Cao Q, Liu H, Pan H, Lv J, Feng Y, Xu F, Huang S, Xu A. Immunogenicity and safety of HepE Hecolin® in chronic hepatitis B patients at clinically stable stage: An open-label study in China. Hum Vaccin Immunother 2025;21:2448882. [PMID: 39797410 PMCID: PMC11730616 DOI: 10.1080/21645515.2024.2448882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2024] [Revised: 12/24/2024] [Accepted: 12/28/2024] [Indexed: 01/15/2025]  Open
6
Coignard C, Vincent C, Lemée V, Plantier JC, Gautier J, Leboulaire F, Turini M, Demirdjian G, Karagueuzian M, Roulet V, Hey J, Rhodes DW. Performance evaluation of the access anti-HBc IgM Assay on the DxI 9000 access immunoassay analyzer. Diagn Microbiol Infect Dis 2025;112:116862. [PMID: 40305958 DOI: 10.1016/j.diagmicrobio.2025.116862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2025] [Revised: 04/15/2025] [Accepted: 04/16/2025] [Indexed: 05/02/2025]
7
Pfefferkorn M, Brehm J, Brehm M, Honshoven F, Deichsel D, Vernoux L, Pavlovic V, Wat C, Berg T, van Bömmel F. Overrange dilution for improvement of hepatitis B core related antigen as a biomarker: protocol validation and examples for application. Virology 2025;609:110576. [PMID: 40393306 DOI: 10.1016/j.virol.2025.110576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2024] [Revised: 04/14/2025] [Accepted: 05/14/2025] [Indexed: 05/22/2025]
8
Vinh DC. Host-directed immunotherapy for viral infections. Curr Opin Infect Dis 2025;38:313-321. [PMID: 40396398 DOI: 10.1097/qco.0000000000001116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/22/2025]
9
Yeap V, Liou WL, Morvil G, Kumar R. Real-world Prevalence of Hepatitis B Reactivation in Patients With Resolved Hepatitis B Receiving Rituximab and Non-rituximab-based Immunosuppressive Therapy Without Chemoprophylaxis. J Clin Exp Hepatol 2025;15:102551. [PMID: 40276702 PMCID: PMC12018034 DOI: 10.1016/j.jceh.2025.102551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2024] [Accepted: 03/16/2025] [Indexed: 04/26/2025]  Open
10
Pan X, Zhou L, Hu J, Zhai P, Ou X, He F, Pan CQ. Tenofovir Alafenamide Therapy Throughout Pregnancy in Mothers With Hepatitis B. Aliment Pharmacol Ther 2025;62:159-167. [PMID: 40318163 DOI: 10.1111/apt.70173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/03/2025] [Revised: 02/11/2025] [Accepted: 04/16/2025] [Indexed: 05/07/2025]
11
Adlat S, Vázquez Salgado AM, Lee M, Yin D, Wangensteen KJ. Emerging and potential use of CRISPR in human liver disease. Hepatology 2025;82:232-253. [PMID: 37607734 PMCID: PMC10881897 DOI: 10.1097/hep.0000000000000578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Accepted: 08/13/2023] [Indexed: 08/24/2023]
12
Romeo M, Dallio M, Cipullo M, Coppola A, Mazzarella C, Mammone S, Iadanza G, Napolitano C, Vaia P, Ventriglia L, Federico A. Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review. Nutr Rev 2025;83:1327-1343. [PMID: 39992295 DOI: 10.1093/nutrit/nuaf001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2025]  Open
13
Ramier C, Carrat F, Beo VD, Parlati L, Lotto M, Marcellin F, Protopopescu C, Carrieri P, Bourliere M, ANRS/AFEF HEPATHER study group. Unhealthy Behaviours and All-Cause Mortality Among People With Chronic Hepatitis B, With and Without Hepatitis Delta (ANRS CO22 HEPATHER). J Viral Hepat 2025;32:e70033. [PMID: 40448453 DOI: 10.1111/jvh.70033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2025] [Accepted: 05/05/2025] [Indexed: 06/02/2025]
14
De Broucker C, Asselah T. Functional Cure in a Long-term Follow-up of Children With Chronic Hepatitis B. Clin Gastroenterol Hepatol 2025;23:1303-1305. [PMID: 39426644 DOI: 10.1016/j.cgh.2024.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2024] [Accepted: 09/23/2024] [Indexed: 10/21/2024]
15
Choi Y, Park YK, Hur W, Kim G, Bae S. D-cycloserine, a potential candidate for reducing Hepatitis B virus cccDNA in vitro. J Virol Methods 2025;336:115172. [PMID: 40306580 DOI: 10.1016/j.jviromet.2025.115172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2024] [Revised: 04/19/2025] [Accepted: 04/27/2025] [Indexed: 05/02/2025]
16
Maung ST, Chaiteerakij R. Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and Optimising Functional Cure in Chronic Hepatitis B. J Viral Hepat 2025;32:e70040. [PMID: 40478218 DOI: 10.1111/jvh.70040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2025] [Revised: 05/05/2025] [Accepted: 05/22/2025] [Indexed: 06/11/2025]
17
Lee HL, Lee SK, Han JW, Yang H, Nam H, Sung PS, Kim HY, Lee SW, Song DS, Kwon JH, Kim CW, Bae SH, Choi JY, Yoon SK, Jang JW. Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B. JHEP Rep 2025;7:101391. [PMID: 40524695 PMCID: PMC12167479 DOI: 10.1016/j.jhepr.2025.101391] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/08/2024] [Revised: 02/23/2025] [Accepted: 03/07/2025] [Indexed: 06/19/2025]  Open
18
Kim DH, Lee HW. Letter on 'Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma'. Aliment Pharmacol Ther 2025;62:236-237. [PMID: 40474542 DOI: 10.1111/apt.70210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2025] [Revised: 05/15/2025] [Accepted: 05/15/2025] [Indexed: 06/29/2025]
19
Lin M, Xie Y, Wu J, Zhang C, Shi S, Lin N, Tong X, Li Y. Review Article: Drug-Induced Liver Injury Associated With Antibody-Based Therapies in Haematologic Malignancies. Aliment Pharmacol Ther 2025. [PMID: 40566645 DOI: 10.1111/apt.70228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2025] [Revised: 03/24/2025] [Accepted: 06/01/2025] [Indexed: 06/28/2025]
20
Moreau J, Chikhoune L, Poggi C, Stabler S, Letarouilly JG, Hachulla É, Launay D. Safety profile of JAK inhibitors in inflammatory or autoimmune diseases. Rev Med Interne 2025:S0248-8663(25)00651-4. [PMID: 40562664 DOI: 10.1016/j.revmed.2025.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2024] [Revised: 05/25/2025] [Accepted: 06/08/2025] [Indexed: 06/28/2025]
21
Tseng TC, Huang SC, Pan MH, Liu CJ, Chen CJ, Yang WT, Tsai CH, Su TH, Yang HC, Liu CH, Chen PJ, Yang HI, Kao JH. Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold. Gut 2025:gutjnl-2025-334911. [PMID: 40541298 DOI: 10.1136/gutjnl-2025-334911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/30/2025] [Accepted: 05/30/2025] [Indexed: 06/22/2025]
22
Wang J, Hu T, Chi X, Wang H, Liu Y, Xie W, Han J, Qiu Q, Yu K, Huang C, Zhang J, Fu Q, Miao Q, Du Z, Zhu H, Zhang J. Unveiling the clinical spectrum of Porto-Sinusoidal Vascular Disorder (PSVD) with chronic HBV infection: insights from a retrospective Chinese cohort. Dig Liver Dis 2025:S1590-8658(25)00801-1. [PMID: 40541511 DOI: 10.1016/j.dld.2025.05.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2025] [Revised: 05/23/2025] [Accepted: 05/26/2025] [Indexed: 06/22/2025]
23
Chen J, Ji D, Jia J, Zhuang H, Zhang X, Wang FS, Zhang W, Dou X, Tanwandee T, Sarin SK, Maiwall R, Kumar M, Goh GBB, Ghazinyan H, Chutaputti A, Chen PJ, You H, Yu ML, George J, Omata M, Wang GQ, Lau G, APASL Viral Elimination Taskforce. Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysis. Hepatol Int 2025:10.1007/s12072-025-10823-5. [PMID: 40528088 DOI: 10.1007/s12072-025-10823-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/26/2024] [Accepted: 03/08/2025] [Indexed: 06/20/2025]
24
Pinchera B, Trucillo E, D'Agostino A, Di Fusco A, Iuliano A, Ametrano L, Esposito N, Buonomo AR, Gentile I. Update on the management of HDV infection: current events and perspectives. Microb Pathog 2025;206:107805. [PMID: 40516886 DOI: 10.1016/j.micpath.2025.107805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2024] [Revised: 05/24/2025] [Accepted: 06/12/2025] [Indexed: 06/16/2025]
25
Wang L, Ma S, Malhi LR, Wu X, Liu L, Wan X, Zhang Y, Li X, Ge S. Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates. Ann Hepatol 2025:101925. [PMID: 40513882 DOI: 10.1016/j.aohep.2025.101925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2024] [Revised: 03/16/2025] [Accepted: 04/06/2025] [Indexed: 06/16/2025]
26
Vo-Quang E, Rosse D, Ortonne V, Garrigou O, Ingiliz P, Leroy V, Pawlotsky JM, Chevaliez S. Performance of the cobas 5800 System for Hepatitis B virus DNA and Hepatitis C virus RNA quantification. Diagn Microbiol Infect Dis 2025;112:116753. [PMID: 40031380 DOI: 10.1016/j.diagmicrobio.2025.116753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2025] [Revised: 01/31/2025] [Accepted: 02/17/2025] [Indexed: 03/05/2025]
27
Shin YE, Kim JY, Yoo JJ, Kim SG, Kim YS. Evaluating fracture risk with TDF in elderly patients with hepatitis B: A Korean perspective. J Hepatol 2025;82:e301-e303. [PMID: 39577472 DOI: 10.1016/j.jhep.2024.11.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2024] [Revised: 11/06/2024] [Accepted: 11/12/2024] [Indexed: 11/24/2024]
28
Degasperi E, Scholtes C, Testoni B, Renteria SU, Anolli MP, Charre C, Facchetti F, Plissonnier ML, Sambarino D, Perbellini R, Monico S, Callegaro A, García-Pras E, Lens S, Cortese MF, Forns X, Pérez-Del-Pulgar S, Heil M, Levrero M, Zoulim F, Lampertico P. Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta. J Hepatol 2025;82:1004-1011. [PMID: 39662705 DOI: 10.1016/j.jhep.2024.11.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2024] [Revised: 10/02/2024] [Accepted: 11/27/2024] [Indexed: 12/13/2024]
29
Hirode G, Kilany M, Pi S, Kim A, Bhat M, Van Uum R, Lilly LB, Hansen BE, Feld JJ, Selzner N, Janssen HLA. Chronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation. J Viral Hepat 2025;32:e70031. [PMID: 40372086 PMCID: PMC12080295 DOI: 10.1111/jvh.70031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2025] [Revised: 04/22/2025] [Accepted: 04/30/2025] [Indexed: 05/16/2025]
30
Block PD, Lim JK. Unmet needs in the clinical management of chronic hepatitis B infection. J Formos Med Assoc 2025;124:502-507. [PMID: 39155176 DOI: 10.1016/j.jfma.2024.08.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 08/13/2024] [Accepted: 08/14/2024] [Indexed: 08/20/2024]  Open
31
Seremba E, Ssekitoleko R, Ocanit A, Kagimu M, Waiswa M, Nankya-Mutyoba J, Akweny E, Bakainaga A, Lawrence M, Kabugo C, Ocama P. Management of chronic hepatitis B in Uganda: A five-year experience following the initiation of a national sensitization and care campaign. J Virus Erad 2025;11:100588. [PMID: 40182694 PMCID: PMC11964627 DOI: 10.1016/j.jve.2025.100588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2025] [Revised: 03/03/2025] [Accepted: 03/04/2025] [Indexed: 04/05/2025]  Open
32
van Bömmel F, Degasperi E, van Bömmel A, Facchetti F, Sambarino D, Deichsel D, Brehm J, Kamga Wouambo R, Maier M, Pfefferkorn M, Berg T, Lampertico P. Dynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year study. Hepatol Commun 2025;9:e0708. [PMID: 40377494 PMCID: PMC12088637 DOI: 10.1097/hc9.0000000000000708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2024] [Accepted: 01/02/2025] [Indexed: 05/18/2025]  Open
33
Lai JCT, Wong GLH, Tse YK, Hui VWK, Lai MSM, Chan HLY, Wong VWS, Yip TCF. Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: A systematic review and meta-analysis. J Hepatol 2025;82:992-1003. [PMID: 39577468 DOI: 10.1016/j.jhep.2024.11.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2024] [Revised: 11/10/2024] [Accepted: 11/13/2024] [Indexed: 11/24/2024]
34
Ogawa E, Enomoto M. Blowin' in the Wind: Air Pollution and the Risk of Hepatocellular Carcinoma. Liver Int 2025;45:e16171. [PMID: 40423520 DOI: 10.1111/liv.16171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/27/2024] [Accepted: 11/04/2024] [Indexed: 05/28/2025]
35
Yang S. Letter: Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma. Aliment Pharmacol Ther 2025;61:1973-1974. [PMID: 40205956 DOI: 10.1111/apt.70136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/21/2025] [Revised: 03/30/2025] [Accepted: 03/30/2025] [Indexed: 04/11/2025]
36
Wen X, Liu M, Fan Y, Xu J, Wang Z, Mao L, Gu W, Shi X, Xu J. Depalmitoylase ABHD16A negatively regulates the anti-hepatitis B virus activity of IFITM1. Microbiol Spectr 2025:e0309524. [PMID: 40434075 DOI: 10.1128/spectrum.03095-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2024] [Accepted: 04/25/2025] [Indexed: 05/29/2025]  Open
37
Duong H, Ngo M, Dao T, Hoang T, Nguyen U, Ho T. Sensitive Detection of Plasma Fibrinogen Chain A mRNA in Hepatocellular Carcinoma Using Semi-Nested RT-PCR. Diagnostics (Basel) 2025;15:1364. [PMID: 40506936 PMCID: PMC12155491 DOI: 10.3390/diagnostics15111364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2025] [Revised: 05/20/2025] [Accepted: 05/27/2025] [Indexed: 06/16/2025]  Open
38
Praguylertluck W, Kaewdech A, Chamroonkul N, Piratvisuth T, Sripongpun P. Effect of switching from prior Nucleos(t)ide Analogue(s) to Tenofovir alafenamide on lipid profile and cardiovascular risk in patients with Chronic Hepatitis B. PLoS One 2025;20:e0324897. [PMID: 40424405 PMCID: PMC12112372 DOI: 10.1371/journal.pone.0324897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2025] [Accepted: 05/04/2025] [Indexed: 05/29/2025]  Open
39
Yang B, Yang T, Hou C, Li Y, Wang Q. Patients with chronic hepatitis B exhibiting significant inflammation and fibrosis should pay particular attention to the status of hepatic steatosis during antiviral therapy. Virol J 2025;22:164. [PMID: 40420107 DOI: 10.1186/s12985-025-02703-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2024] [Accepted: 03/11/2025] [Indexed: 05/28/2025]  Open
40
Li W, Huang R, Wang J, Zhang B, Wang Q, Feng J, Xing T. Development and validation of a new predictive model for the immune tolerance stage of chronic HBV infection based on the liver histopathological changes. BMC Gastroenterol 2025;25:408. [PMID: 40426052 PMCID: PMC12107786 DOI: 10.1186/s12876-025-03999-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2024] [Accepted: 05/15/2025] [Indexed: 05/29/2025]  Open
41
Lu Y, Li T, Song L, Fan Q, Wang D, Wang P, Han Y, Zhou X. MDSCs in Chronic Liver Disease: Updates and Future Challenges. J Gastroenterol Hepatol 2025. [PMID: 40405825 DOI: 10.1111/jgh.17008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/18/2025] [Revised: 04/14/2025] [Accepted: 05/09/2025] [Indexed: 05/24/2025]
42
Jin C, Hu B, Liu H, Wang R, Jang J, Su M. Cystathionine gamma-lyase as an inflammatory factor and its link with immune inflammation in hepatitis B virus-related liver disease. Sci Rep 2025;15:17777. [PMID: 40404804 PMCID: PMC12098708 DOI: 10.1038/s41598-025-98922-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2024] [Accepted: 04/15/2025] [Indexed: 05/24/2025]  Open
43
Jian W, Yin Y, Xue J, Chen R, Feng J, Zeng J, He R, Zhou T. Hepatitis surface B antigen clearance induced by long-term tenofovir disoproxil fumarate monotherapy in chronic hepatitis B treatment: a meta-analysis and longitudinal modeling analysis. Virol J 2025;22:158. [PMID: 40405187 PMCID: PMC12100987 DOI: 10.1186/s12985-025-02788-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2025] [Accepted: 05/12/2025] [Indexed: 05/24/2025]  Open
44
Huang R, Do AT, Toyoda H, Li J, Yasuda S, Tsai PC, Yeh ML, Trinh H, Chau A, Huang DQ, Ogawa E, Ito T, Kozuka R, Atsukawa M, Marciano S, Honda T, Watanabe T, Itokawa N, Preda CM, Tseng CH, Barreira A, Inoue K, Takahashi H, Uojima H, Kawashima K, Hsu YC, Marin RI, Sandra I, Ishigami M, Li J, Zhang J, Do S, Maeda M, Lee DH, Chuang WL, Dai CY, Huang JF, Huang CF, Cheung R, Buti M, Tanaka Y, Yuen MF, Enomoto M, Gadano A, Lim SG, Yu ML, Wu C, Nguyen MH. Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study. Aliment Pharmacol Ther 2025. [PMID: 40395146 DOI: 10.1111/apt.70194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/05/2025] [Revised: 03/12/2025] [Accepted: 05/05/2025] [Indexed: 05/22/2025]
45
Hu Q, Zhang X, Cao X, Tao S, Chen C, Lu M, Zhao C, Chen L, Li Q, Qi X, Huang Y. Long-term effects of peginterferon-based therapy versus nucleos(t)ide analogue monotherapy in non-cirrhotic HBeAg-positive chronic hepatitis B patients. Antiviral Res 2025;240:106192. [PMID: 40403849 DOI: 10.1016/j.antiviral.2025.106192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2025] [Revised: 05/07/2025] [Accepted: 05/19/2025] [Indexed: 05/24/2025]
46
Chang LJ, Hao CQ, Rao GR, Xu LL, Li J, Cheng Y, Zheng LJ, Wu CW, Chen HX, Chen ZR, Lian JQ, Wu SH, Luo LM, Zhang WL, Zhang Y. Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study. Virol J 2025;22:146. [PMID: 40390028 PMCID: PMC12087174 DOI: 10.1186/s12985-025-02761-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2025] [Accepted: 04/25/2025] [Indexed: 05/21/2025]  Open
47
Ma HY, Yang XY, Tian YX, Li XD, He YL, Yang Q, Zheng MH, Zheng YB, Yu Y, Xu LY, Wang QN, Zhang T, Shi Y, Fan YC. Performance of the AASLD, EASL, and APASL Clinical Practice Guidelines in"grey zone"stages of Chinese patients with chronic hepatitis B. Hepatol Int 2025:10.1007/s12072-025-10833-3. [PMID: 40360826 DOI: 10.1007/s12072-025-10833-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/23/2024] [Accepted: 04/11/2025] [Indexed: 05/15/2025]
48
Song S, Su Q, Yan Y, Ji H, Sun H, Feng K, Nuermaimaiti A, Halemubieke S, Mei L, Liu X, Lu Z, Chang L, Wang L. Identification and characteristics of mutations promoting occult HBV infection by ultrasensitive HBsAg assay. J Clin Microbiol 2025;63:e0207124. [PMID: 40162819 PMCID: PMC12077177 DOI: 10.1128/jcm.02071-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2025] [Accepted: 03/11/2025] [Indexed: 04/02/2025]  Open
49
Huang YJ, Wang JS, Chen CH, Chang CH, Liao SC, Lee SW, Peng YC, Lee TY, Li TC. Predictive factors and clinical outcomes in decompensated non-cirrhotic chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate. J Formos Med Assoc 2025:S0929-6646(25)00222-0. [PMID: 40360345 DOI: 10.1016/j.jfma.2025.05.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2024] [Revised: 04/03/2025] [Accepted: 05/08/2025] [Indexed: 05/15/2025]  Open
50
Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, Lens S, Testoni B, Lai-Hung Wong G, Russo FP. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2025:S0168-8278(25)00174-6. [PMID: 40348683 DOI: 10.1016/j.jhep.2025.03.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/20/2025] [Accepted: 03/20/2025] [Indexed: 05/14/2025]
PrevPage 1 of 76 123457576Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA